Research behind the skin cancer prevention campaign "If You Could See UV" has found that evoking fear of ultraviolet (UV) radiation exposure—through a visually striking metaphor—helped motivate young adults to protect their ...
Apr 6, 2026
0
2
Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, fibroblast cells rush in to make fibronectin and collagen, which are two major extracellular matrix proteins ...
Apr 2, 2026
0
6
Folks with severe plaque psoriasis often have to choose between convenient pills that don't work very well or highly effective injections that come with the hassle of needles. That trade-off may soon change. New clinical ...
Apr 2, 2026
0
7
In a consensus statement published online March 25 in JAMA Dermatology, internationally agreed-upon severity criteria are presented for vitiligo.
Apr 2, 2026
0
4
Melanoma is a deadly form of skin cancer that is typically removed surgically. Now, researchers publishing in ACS Nano report they have developed a potential noninvasive treatment for melanoma in the form of a stretchy, heat-activated ...
Apr 1, 2026
0
99
For adults with dermatomyositis, brepocitinib, an oral tyrosine kinase 2/Janus kinase 1 inhibitor, demonstrates significant benefits at a 30-mg dose compared with placebo, according to a study published online March 28 in ...
Apr 1, 2026
0
1
Chronic wounds affect approximately 2% of the population in developed countries. Existing treatments are expensive and may cause side effects. In his doctoral thesis, Amal D. Premarathna shows that a promising alternative ...
Mar 31, 2026
0
6
For patients undergoing total hip arthroplasty (THA), those with cutaneous psoriasis (PsC) and psoriatic arthritis (PsA) have an increased risk for complications, according to a study published online March 22 in the Journal ...
Mar 31, 2026
0
2
Collagen supplements have become one of the bestselling products in the wellness industry, promising everything from smoother skin to stronger joints. But do they actually work?
Mar 29, 2026
0
76
The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric ...
Mar 25, 2026
0
3
